The effectiveness of the central non-opioid analgesic nefopam in the treatment of acute pain syndrome in participants of a special military operation.
- 作者: Sergoventsev A.A.1, Shchegolev A.V.2, Chuprina A.P.1, Gritsai A.N.2, Arsentiev L.V.2, Aksenfeld D.I.3, Usoltsev E.A.4, Soloviev G.S.5
-
隶属关系:
- Main Military Medical Directorate of the Russian Defense Ministry
- The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
- 1602nd Military Clinical Hospital of the Russian Defense Ministry
- 442nd Military Clinical Hospital of the Russian Defense Ministry
- 1472nd Naval Clinical Hospital of the Russian Defense Ministry
- 期: 卷 345, 编号 5 (2024)
- 页面: 31-39
- 栏目: Treatment and prophylactic issues
- URL: https://journals.eco-vector.com/0026-9050/article/view/631484
- DOI: https://doi.org/10.52424/00269050_2024_345_5_31
- ID: 631484
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The goal is to evaluate the effectiveness and safety of the use of nefopam in the provision of medical care. The study of the effectiveness of nefopam was carried out in 2 groups: the 1st group (n=53) included patients who, because of dissatisfaction with analgesia, were additionally prescribed a non-steroidal anti-inflammatory drug and trimeperidine at a dose of 20 mg within 30 minutes after the administration of nefopam; Group 2 (n=201) received only nefopam. The administration of nefopam was accompanied by a decrease in pain intensity, normalization of heart rate, and respiratory movements in all 254 patients. The reason for the ineffective relief of pain in group 1 was the development of an initially severe pain syndrome. The likelihood of developing side effects (nausea, vomiting, tremors, sweating, subcutaneous erythema) was 2–9 times lower in group 2. Nefopam is recommended for the relief of pain of moderate intensity; its effectiveness for the relief of severe pain is insufficient.
全文:
作者简介
A. Sergoventsev
Main Military Medical Directorate of the Russian Defense Ministry
Email: vmeda-na@mil.ru
заслуженный врач РФ, кандидат медицинских наук, генерал-майор медицинской службы
俄罗斯联邦, MoscowA. Shchegolev
The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
Email: vmeda-na@mil.ru
профессор, полковник медицинской службы
俄罗斯联邦, St. PetersburgA. Chuprina
Main Military Medical Directorate of the Russian Defense Ministry
Email: vmeda-na@mil.ru
доцент, полковник медицинской службы
俄罗斯联邦, MoscowA. Gritsai
The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
编辑信件的主要联系方式.
Email: vmeda-na@mil.ru
кандидат медицинских наук, полковник медицинской службы
俄罗斯联邦, St. PetersburgL. Arsentiev
The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation
Email: vmeda-na@mil.ru
кандидат медицинских наук, подполковник медицинской службы
俄罗斯联邦, St. PetersburgD. Aksenfeld
1602nd Military Clinical Hospital of the Russian Defense Ministry
Email: vmeda-na@mil.ru
подполковник медицинской службы
俄罗斯联邦, Rostov-on-DonE. Usoltsev
442nd Military Clinical Hospital of the Russian Defense Ministry
Email: vmeda-na@mil.ru
подполковник медицинской службы
俄罗斯联邦, St. PetersburgG. Soloviev
1472nd Naval Clinical Hospital of the Russian Defense Ministry
Email: vmeda-na@mil.ru
подполковник медицинской служб
俄罗斯联邦, Sevastopol参考
- Абузарова Г.Р., Невзорова Д.В., Кумирова Э.В. и др. Обезболивание взрослых и детей при оказании медицинской помощи: Метод. реком. – М.: РНИМУ им. Н.И.Пирогова, 2016. – 94 с.
- Арбух Д.М., Абузарова Г.Р., Алексеева Г.С. Опиоидные анальгетики в терапии болевых синдромов (часть 1) // Вестн. анестезиол. и реаниматол. – 2017. – Т. 14, № 3. – С. 58–67.
- Овечкин А.М., Баялиева А.Ж., Ежевская А.А. и др. Послеоперационное обезболивание. Клинические рекомендации // Вестн. интенсив. тер. им. А.И.Салтанова. – 2019. – № 4. – C. 9–33
- Осипова Н.А., Береснев В.А., Петрова В.В. Мультимодальная системная фармакотерапия послеоперационного болевого синдрома // Consilium Medicum. – 2001. – Т. 3, № 9. – C. 432–438.
- Страчунский Л.С., Козлов С.Н. Нестероидные противовоспалительные средства: Метод. пособие. – Смоленск, 2009. – 54 с.
- Щеголев А.В. Лахин Р.Е., Грицай А.Н. Анестезиологическая и реаниматологическая помощь раненым // В кн.: Военно-полевая хирургия. Национальное руководство / Под ред. И.М.Самохвалова. – 2-е изд., перераб. и доп. – М.: ГОЭТАР-Медиа, 2024. – Гл. 9. – С. 249–305.
- Evidence based medicine consult. The mechanism of meperidine induced seizures and risk factors. URL:http://EBM Consult (дата обращения: 24.01.2024).
- Gillman P.K. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity // Br. J. Anaesth. – 2005. – Vol. 95, N 4. – P. 434–441.
- Girard P., Chauvin M., Verleye M. Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studies // Clin. Exp. Pharmacol. Physiol. – 2016. – Vol. 27, N 43. – P. 3–12.
- Kazuhiko Fukuda. Опиоиды // «Анестезия» Рональда Миллера: в 4 т. / Под ред. Р.Миллера; пер с англ. – СПб: Человек, 2015. – Т. 2, гл. 27. – С. 823–880.
- Kim K.H., Abdi S. Rediscovery of Nefopam for the Treatment of Neuropathic Pain // Korean J. Pain. – 2014. – Vol. 27, N 2. – P. 103–111.
- Meperidine Dosage. Medically reviewed by Drugs.com. Last updated on Aug 4, 2023. URL: http://Drugs.com (дата обращения: 24.01.2024).
- Military advanced regional anesthesia and analgesia handbook. – 2nd edition. – Oxford: University press, 2020. – 336 p.
- Nair A.S. Nefopam: Another Pragmatic Analgesic in Managing Chronic Neuropathic Pain // Indian J. Palliat. Care. – 2019. – Vol. 25, N 3. – P. 482–483.
- Rawal G., Kumar. R., Yadav S. et al. Pain management in intensive care unit: a brief review // Med. Res. Chronicles. – 2019. – Vol. 6, N 6. – P. 302–309.
- Schenk M., Wirz S. Serotonin syndrome and pain medication: What is relevant for practice // Schmerz. – 2015. – Vol. 29, N 2. – P. 229–251.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).